Bronchial Asthma Clinical Trials

16 recruiting

Bronchial Asthma Trials at a Glance

16 actively recruiting trials for bronchial asthma are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Sohag, Nanchang, and Guangzhou. Lead sponsors running bronchial asthma studies include Anhui Palo Alto Pharmaceuticals, Inc., Sohag University, and AstraZeneca.

Browse bronchial asthma trials by phase

Treatments under study

About Bronchial Asthma Clinical Trials

Looking for clinical trials for Bronchial Asthma? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchial Asthma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchial Asthma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting

Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.

Bronchial AsthmaPulmonary Cystic Fibrosis
The Institute of Molecular and Translational Medicine, Czech Republic450 enrolled1 locationNCT04157361
Recruiting

Fasenra Pediatric Japan Post-Marketing Study(PMS)

Bronchial Asthma
AstraZeneca40 enrolled11 locationsNCT06427876
Recruiting
Phase 2

Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma

Bronchial Asthma
Anhui Palo Alto Pharmaceuticals, Inc.30 enrolled1 locationNCT07324707
Recruiting
Phase 2

Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma

Bronchial Asthma
Anhui Palo Alto Pharmaceuticals, Inc.60 enrolled1 locationNCT07326995
Recruiting
Not Applicable

Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

Bronchial AsthmaChronic Obstructive Pulmonary Disease (COPD)
Charles University, Czech Republic1,000 enrolled1 locationNCT07183657
Recruiting
Not Applicable

Community Exercise Treating Effect on Cardiopulmonary Disease Patients

Heart FailureCardiomyopathyCoronary Heart Disease (CHD)+5 more
Guangdong Provincial People's Hospital200 enrolled1 locationNCT07154355
Recruiting

The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease

COPDBronchial AsthmaBronchiectasis+4 more
University College, London120 enrolled1 locationNCT07060079
Recruiting

The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.

Coronary Heart DiseaseEpilepsyStroke+4 more
Russian Federation of Anesthesiologists and Reanimatologists16,000 enrolled38 locationsNCT03945968
Recruiting

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Lung CancerLung InfectionCOPD+13 more
ChromX Health10,000 enrolled1 locationNCT06528418
Recruiting
Not Applicable

FeNO Detection in Asthma Diagnosis: A New Technology Approach

Bronchial AsthmaAirway Disease
Novlead Inc.170 enrolled2 locationsNCT06852911
Recruiting
Not Applicable

Behavioral Changes Among Asthmatic Children in Sohag Universty Hospital

Bronchial Asthma
Sohag University100 enrolled1 locationNCT06624735
Recruiting
Not Applicable

Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma

Bronchial Asthma
Foundation University Islamabad32 enrolled1 locationNCT06609941
Recruiting

A Study of Step-up in Bronchial Asthma as a New End Point in Asthma Control (SURFE)

Bronchial Asthma
Ain Shams University100 enrolled1 locationNCT05632081
Recruiting

Effects of Pulmonary Diseases and Their Treatment on Cardiac Function

COPDBronchial AsthmaIdiopathic Pulmonary Fibrosis
Ayham Daher120 enrolled1 locationNCT05042219
Recruiting

Risk of Chronic Kidney Disease in Bronchial Asthma

Bronchial Asthma
Sohag University100 enrolled1 locationNCT06472596
Recruiting
Not Applicable

Setting a PERSONalized Outcome in ASthma: the PERSONAS Study. A Patient Driven Outcome (PDO) Study

Bronchial Asthma
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico190 enrolled12 locationsNCT06320119